Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers

There is a vital need for improved therapeutic strategies that are effective in both primary and metastatic triple-negative breast cancer (TNBC). Current treatment options for TNBC patients are restricted to chemotherapy; however tyrosine kinases are promising druggable targets due to their high exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Linklater, Erik S., Tovar, Elizabeth A., Essenburg, Curt J., Turner, Lisa, Madaj, Zachary, Winn, Mary E., Melnik, Marianne K., Korkaya, Hasan, Maroun, Christiane R., Christensen, James G., Steensma, Matthew R., Boerner, Julie L., Graveel, Carrie R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342523/
https://www.ncbi.nlm.nih.gov/pubmed/27655711
http://dx.doi.org/10.18632/oncotarget.12065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342523/
https://www.ncbi.nlm.nih.gov/pubmed/27655711
http://dx.doi.org/10.18632/oncotarget.12065

Ejemplares similares